This inventor holds 1 USPTO granted patent. Top assignee: Nantong University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Guicai Li - Innovator in Biomedical Engineering
Introduction
Guicai Li is a prominent inventor based in Nantong, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative hemostatic agents. His work focuses on addressing critical medical challenges, such as managing hemorrhage in specific conditions.
Latest Patents
Guicai Li holds a patent for a hemostatic agent designed for jaw central hemangioma hemorrhage. The patent describes a preparation method and application of the hemostatic agent, which involves the reaction of chitosan powder and organic weak acid in organic alcohol to create chitosan weak acid salt. This agent exhibits excellent fluidity and plasticity, allowing it to effectively reach the site of hemorrhage without causing tissue damage. Additionally, it has antibacterial properties, which help prevent cross-infection and facilitate easy cleaning and removal. This innovative solution is poised for clinical promotion due to its effectiveness in treating massive hemorrhage.
Career Highlights
Guicai Li is affiliated with Nantong University, where he continues to advance his research in biomedical engineering. His dedication to innovation has led to the development of solutions that significantly improve patient outcomes in medical settings.
Collaborations
Guicai Li collaborates with Jiang Zhu, a fellow researcher, to further enhance the impact of their work in the biomedical field.
Conclusion
Guicai Li's contributions to biomedical engineering, particularly through his patented hemostatic agent, demonstrate his commitment to improving medical treatments. His innovative approach addresses critical health challenges and holds promise for future clinical applications.